BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27079740)

  • 1. Treatment of membranous nephropathy with mizoribine: A control trial.
    Wang X; Song X; Liu Y; Zhang W; An W; Tu Y
    Life Sci; 2016 Jun; 154():75-8. PubMed ID: 27079740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of mizoribine pulse therapy in adult membranous nephropathy.
    Wang X; Zhang M; Zhang W; Liu Y; Han Y; Chang W
    Int Urol Nephrol; 2021 Apr; 53(4):725-731. PubMed ID: 33159256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of mizoribine followed by low-dose prednisone in patients with idiopathic membranous nephropathy and nephrotic-range proteinuria.
    Matsumoto Y; Shimada Y; Nojima Y; Moriki T
    Ren Fail; 2013 Aug; 35(7):936-41. PubMed ID: 23815417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome.
    Saito T; Iwano M; Matsumoto K; Mitarai T; Yokoyama H; Yorioka N; Nishi S; Yoshimura A; Sato H; Ogahara S; Sasatomi Y; Kataoka Y; Ueda S; Koyama A; Maruyama S; Nangaku M; Imai E; Matsuo S; Tomino Y;
    Clin Exp Nephrol; 2017 Dec; 21(6):961-970. PubMed ID: 27783276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fanconi syndrome in an elderly patient with membranous nephropathy during treatment with the immunosuppressant mizoribine.
    Nishikawa S; Takahashi N; Nishikawa Y; Yokoi S; Morita S; Shimamoto Y; Sakashita S; Nishimori K; Kobayashi M; Fukushima S; Mikami D; Kimura H; Kasuno K; Naiki H; Iwano M
    CEN Case Rep; 2023 Feb; 12(1):32-38. PubMed ID: 35749014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-proteinuric effect of mizoribine monotherapy in three patients with membranous nephropathy.
    Fujita T; Shimizu C; Ito K; Fuke Y; Satomura A; Matsumoto K
    Clin Nephrol; 2010 Jul; 74(1):81-2. PubMed ID: 20557872
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of mizoribine combined with losartan in the treatment of IgA nephropathy: a multicenter, randomized, controlled study.
    Xie Y; Huang S; Wang L; Miao L; Zhang A; Li Y; Wu X; Wang L; Liu S; Lie C; Chen P; Chen X
    Am J Med Sci; 2011 May; 341(5):367-72. PubMed ID: 21293249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey).
    Shibasaki T; Koyama A; Hishida A; Muso E; Osawa G; Yamabe H; Shiiki H; Makino H; Sato H; Ishikawa I; Maeda K; Tomita K; Arakawa M; Ishida M; Sato M; Nagase M; Kashihara N; Yorioka N; Koike T; Saito T; Harada T; Mitarai T; Sugisaki T; Nagasawa T; Tomino Y; Nojima Y; Kobayashi Y; Sakai O
    Clin Exp Nephrol; 2004 Jun; 8(2):117-26. PubMed ID: 15235928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of mizoribine therapy in elderly patients with membranous nephropathy: comparison with patients not receiving mizoribine.
    Ito T; Mochizuki K; Oka T; Hanada K; Tanabe K
    Int Urol Nephrol; 2015 Jan; 47(1):131-5. PubMed ID: 25298141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mizoribine combined with steroids and dietary sodium restriction on the treatment of primary membranous nephropathy: a prospective study.
    Wang X; Zhang M; Sun N; Chang W
    Clin Exp Nephrol; 2023 Mar; 27(3):211-217. PubMed ID: 36574107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing mizoribine administration from three divided doses to one single dose induced remission of relapsed membranous nephropathy.
    Nishioka Y; Horita Y; Tadokoro M; Taura K; Suyama N; Miyazaki M; Harada T; Kohno S
    Nephrol Dial Transplant; 2006 Aug; 21(8):2337-8. PubMed ID: 16547120
    [No Abstract]   [Full Text] [Related]  

  • 12. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial.
    Ramachandran R; Hn HK; Kumar V; Nada R; Yadav AK; Goyal A; Kumar V; Rathi M; Jha V; Gupta KL; Sakhuja V; Kohli HS
    Nephrology (Carlton); 2016 Feb; 21(2):139-46. PubMed ID: 26205759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose Rituximab Therapy for Refractory Idiopathic Membranous Nephropathy: A Single-center Experience.
    Katsuno T; Ozaki T; Kim H; Kato N; Suzuki Y; Akiyama S; Ishimoto T; Kosugi T; Tsuboi N; Ito Y; Maruyama S
    Intern Med; 2017; 56(13):1679-1686. PubMed ID: 28674357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil in idiopathic membranous nephropathy: a clinical trial with comparison to a historic control group treated with cyclophosphamide.
    Branten AJ; du Buf-Vereijken PW; Vervloet M; Wetzels JF
    Am J Kidney Dis; 2007 Aug; 50(2):248-56. PubMed ID: 17660026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
    Branten AJ; Wetzels JF
    Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of mizoribine on bullous pemphigoid associated with membranous nephropathy.
    Kawakami T; Fujita A; Shirai S; Kimura K; Soma Y
    J Am Acad Dermatol; 2009 Mar; 60(3):523-4. PubMed ID: 19231657
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of immunosuppressive therapies for IgA nephropathy after tonsillectomy: three-course versus one-course steroid pulse combined with mizoribine.
    Kaneko T; Arai M; Ikeda M; Morita M; Watanabe Y; Hirama A; Shimizu A; Tsuruoka S
    Int Urol Nephrol; 2015 Nov; 47(11):1823-30. PubMed ID: 26433884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy.
    Jha V; Ganguli A; Saha TK; Kohli HS; Sud K; Gupta KL; Joshi K; Sakhuja V
    J Am Soc Nephrol; 2007 Jun; 18(6):1899-904. PubMed ID: 17494881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: a multicenter randomized controlled trial.
    Chen M; Li H; Li XY; Lu FM; Ni ZH; Xu FF; Li XW; Chen JH; Wang HY;
    Am J Med Sci; 2010 Mar; 339(3):233-8. PubMed ID: 20220333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective treatment administration of cyclophosphamide in membranous nephropathy.
    Dede F; Ayili D; Sahiner S
    J Nephrol; 2008; 21(4):560-5. PubMed ID: 18651546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.